NLRP3 and Alzheimer disease: Our subsequent experiments showed that miR-212-3p overexpression reduced the expressions of NLRP3, cleaved Caspase-1, GSDMD-N, IL-1β, and IL-18, indicating the properties of miR-212-3p against pyroptosis and inflammation in AD rats.